Once again, the University of Ottawa Heart Institute had more than 40 clinical and research presentations on the program at the annual American Heart Association Scientific Sessions. These, along with other major developments in the world of cardiovascular medicine, made for a lively conference. New...
Search
Displaying 41 - 60 of 380
Several Heart Institute staffers offered their expertise in invited talks touching on a broad range of topics. Scientist Erik Suuronen, PhD, uses tissue engineering techniques to develop methods for regenerating damaged heart muscle. In his presentation, called “The Matrix: Stem Cell Delivery...
Some of the biggest news to come out of AHA this year was the results from preliminary clinical trials of two new LDL cholesterol-lowering drugs that show a substantial decrease in LDL levels well below the reductions seen with statins or ezetimibe alone. The new drugs belong to a class called PCSK9...
The use of stem cells for regenerating damaged heart tissue offers great potential, but many technical questions remain. Understanding which cell types are most beneficial and how they should be employed is a central issue. Several clinical trials involving stem cells were presented at AHA. Two were...
Research from around the world was presented at the 2014 American Heart Association (AHA) Scientific Sessions in November. The following highlights range from large drug trials to new information about the causes and of heart disease and the value of good heart health. Preventing Clots Following...
More than 32,000 Canadians go into cardiac arrest each year outside of a hospital and more than 90 per cent of them die. In many cases, this is because bystanders didn’t have adequate knowledge of CPR or access to an automated external defibrillator (AED). Guidelines and studies presented at the...
Although most cases of high blood pressure have no easily identifiable cause, the condition’s effects are clear, including increased risk of stroke, heart attack, and heart failure. The medical consensus is that using medications to lower blood pressure benefits patients, but how low has remained an...
Over the last decade, much has been learned about the genetic risk factors for cardiovascular disease. In the long run, as researchers uncover how variations in these genes lead to heart disease, this knowledge may lead to new preventive drugs and treatments. But in the meantime, doctors have been...
Canadians eat more salt than is good for them, increasing their risk of high blood pressure, heart disease, and stroke. The Heart and Stroke Foundation estimates that the average adult Canadian consumes about 3,400 mg of sodium per day (roughly one-and-a-half teaspoons), most of it from processed...
At this year’s premier international gathering for heart disease, the American Heart Association Scientific Sessions, sharing expertise was a major aspect of the University of Ottawa Heart Institute’s presence. In Ask the Expert and seminar sessions, surgeons Marc Ruel, Munir Boodhwani, David...
Each of us breathes in 10,000 or more litres of air every day, so it’s no surprise that the quality of that air can impact our health. Whether in large urban centres or more rural settings, air pollution can be a fact of life. As it turns out, these airborne pollutants—ground-level ozone, nitrogen...
February is the shortest and coldest month of the year, but also the most important one for our heart health. That’s because February is Heart Month, a time to reflect on the importance of our cardiovascular health and to learn about how we can manage our risk factors for heart disease. The...
The American Heart Association Scientific Sessions is the largest conference for cardiovascular science and medicine in the world. The staff of the University of Ottawa Heart Institute is once again responsible for many expert clinical talks and research presentations. This guide highlights those...
The American Heart Association Scientific Sessions is the largest conference for cardiovascular science and medicine in the world. The staff of the University of Ottawa Heart Institute is once again responsible for many expert clinical talks and research presentations. This guide highlights those...
The world’s largest cardiovascular conference, the American Heart Association Scientific Sessions, convenes in New Orleans on November 12. The Ottawa Heart Institute has 45 program items on the agenda covering a wide range of science and clinical practice. Find it all with our program guide. 2016...
The University of Ottawa Heart Institute (UOHI) is establishing a network to improve cardiovascular disease (CVD) prevention and care in women. The Public Health Agency of Canada (PHAC) and the UOHI Foundation are funding the project, valued at more than $1.2M plus in-kind contributions. CVD is the...
Aortic disease is often referred to as a silent condition because there are usually no symptoms to alert either the patient or doctor. The consequences, however, can be catastrophic, as in the case of an aortic dissection—a tear in the wall of this major artery. Rapid diagnosis and treatment are...
After nearly 50 years, the renowned cardiologist is hanging up his stethoscope
This page summarizes the awards for the 2025 Canadian Women's Heart Health Summit that are available for application and past winners.
Ottawa Heart Institute staff and trainees featured prominently among award recipients again this year at the Canadian Cardiovascular Congress, with awards from several differ professional societies. Distinguished Teacher Award, Canadian Cardiovascular Society Kwan-Leung Chan, MD A cardiologist with...